Search for: "Sanofi" Results 61 - 80 of 1,187
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Aug 2023, 9:16 am by Kluwer Patent blogger
Settlement As was pointed out in an article of EIP Amar, ‘many of the parties involved in (…) initial infringement actions are pairings familiar from litigation already being fought in UK, Germany or US, such as Edwards Life Sciences against Meril, Ocado against Autostore and Amgen against Sanofi / Regeneron’. [read post]
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
31 Jul 2023, 1:18 am by Rose Hughes
Interestingly, the US Supreme Court in the recent decision on enablement in Amgen v Sanofi also took great pains to emphasise that the law of enablement of broadly claimed inventions was originally derived from, and continues to apply, to the mechanical field (IPKat). [read post]
28 Jul 2023, 8:26 am by Levin Papantonio
However, it follows a similar action filed in May by Lake County, Illinois in which the County accuses Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, and OptumRx are accused of violating the state's Consumer Fraud Act and the RICO Act. [read post]
23 Jul 2023, 9:53 pm by Patent Docs
Sanofi, where the Supreme Court addressed the enablement requirement for patent claims directed to antibodies.... [read post]
20 Jul 2023, 3:44 am by Rose Hughes
This is the second post considering the Court of Appeal decision on plausibility in Sandoz v BMS ([2023] EWCA Civ 472), in the context of the Enlarged Board of Appeal decision in G 2/21. [read post]
20 Jul 2023, 1:42 am by Rose Hughes
This Kat took the enforced confinement of a rainy summer weekend to finally delve deeper into one of the key patent decisions from the UK courts this year. [read post]